Jump to navigation Jump to search
|Chemical and physical data|
|Molar mass||145.9 kg/mol|
|(what is this?)|
Rontalizumab is a humanized monoclonal antibody being developed by Genentech. As of November 2009[update], it is being investigated in a clinical trial for the treatment of systemic lupus erythematosus.
|This monoclonal antibody-related article is a stub. You can help Wikipedia by expanding it.|
|This antineoplastic or immunomodulatory drug article is a stub. You can help Wikipedia by expanding it.|